(2008). Small airways: an important but neglected target in the treatment of obstructive airway diseases. Tr Pharmacol Sci
(2011). Small-airway obstruction and emphysema in chronic obstructive pulmonary disease.
(2007). The myofibroblast: one function, multiple origins.
(2010). The preclinical pharmacology of roflumilast - A selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease. Pulm Pharmacol Ther
(2004). Therapeutic responses in asthma and COPD.
(1993). Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts.
(2001). Umeda A: Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med
(2000). Wrana JL: Smads as transcriptional co-modulators.